Clinical Trial Update: Microbiota trAnSplant ThERaPy In hEpatiC Encephalopathy (MASTERPIECE) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial MASTERPIECE evaluating microbiota transplant therapy for hepatic encephalopathy in cirrhosis; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy
• Liver Cirrhosis

Drugs mentioned

• MASTERPIECE Microbiota Transplant Therapy (Microbiota transplant therapy)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Hepatic Encephalopathy, Cirrhosis | Phase 2 | Status: NOT_YET_RECRUITING